Mucosal TLR5 activation controls healthspan and longevity

Jae Sung Lim,Eun Jae Jeon,Hye Sun Go,Hyung-Jin Kim,Kye Young Kim,Thi Quynh Trang Nguyen,Da Young Lee,Kyu Suk Kim,Federico Pietrocola,Seol Hee Hong,Shee Eun Lee,Kyoung-Shim Kim,Tae-Shin Park,Dong-Hee Choi,Yu-Jin Jeong,Jong-Hwan Park,Hyeon Sik Kim,Jung-Joon Min,Yong Sook Kim,Joon Tae Park,Jae-Ho Cho,Gil-Woo Lee,Ji Hyeon Lee,Hyon E. Choy,Sang Chul Park,Chul-Ho Lee,Joon Haeng Rhee,Manuel Serrano,Kyung A Cho
DOI: https://doi.org/10.1038/s41467-023-44263-2
IF: 16.6
2024-01-02
Nature Communications
Abstract:Abstract Addressing age-related immunological defects through therapeutic interventions is essential for healthy aging, as the immune system plays a crucial role in controlling infections, malignancies, and in supporting tissue homeostasis and repair. In our study, we show that stimulating toll-like receptor 5 (TLR5) via mucosal delivery of a flagellin-containing fusion protein effectively extends the lifespan and enhances the healthspan of mice of both sexes. This enhancement in healthspan is evidenced by diminished hair loss and ocular lens opacity, increased bone mineral density, improved stem cell activity, delayed thymic involution, heightened cognitive capacity, and the prevention of pulmonary lung fibrosis. Additionally, this fusion protein boosts intestinal mucosal integrity by augmenting the surface expression of TLR5 in a certain subset of dendritic cells and increasing interleukin-22 (IL-22) secretion. In this work, we present observations that underscore the benefits of TLR5-dependent stimulation in the mucosal compartment, suggesting a viable strategy for enhancing longevity and healthspan.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to improve age - related immunodeficiency through therapeutic interventions in order to promote healthy aging. Specifically, the study explored whether stimulating Toll - like receptor 5 (TLR5) by mucosal delivery of a fusion protein (FP) containing flagellin can effectively extend the lifespan of mice and enhance their healthspan. The paper showed how stimulating TLR5 affects multiple aspects during the aging process, such as reducing hair loss and lens opacity, increasing bone density, enhancing stem cell activity, delaying thymus degeneration, improving cognitive ability and preventing pulmonary fibrosis, etc., thus proposing a possible strategy to enhance longevity and healthspan. The research background mentioned that as people age, the function of the immune system declines. This not only increases the risk of infection and chronic inflammation, but may also lead to the emergence of metabolic and cardiovascular diseases, neurodegenerative diseases and age - related diseases. These changes are manifested at different levels, including a decrease in the production of immune cells in the bone marrow and thymus, a weakening of the function of mature lymphocytes in secondary lymphoid tissues, and a decline in the function of innate immune cells in various tissues. In addition, the elderly also have a weaker response to vaccines, for example, the effectiveness of influenza vaccines and COVID - 19 vaccines is reduced, which further emphasizes the need to strengthen the immune system of the elderly. The paper proved through experiments that delivering FP fusion protein to old mice by nasal administration can significantly improve a variety of age - related health conditions and, to a certain extent, extend the lifespan of mice. This finding provides a new perspective and potential therapeutic strategy for intervening in the aging process by regulating the TLR5 signaling pathway.